Page last updated: 2024-10-27

gabexate and Leukemia, Myeloid

gabexate has been researched along with Leukemia, Myeloid in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakata, Y1

Reviews

1 review available for gabexate and Leukemia, Myeloid

ArticleYear
[Treatment of DIC associated with myelogenous leukemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:10

    Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans; Leukemia, Myeloid

2009